MEDICAL DEVICES

AXENYA MERGES WITH HEALTHCO TO CREATE THE MOST ADVANCED HEALTH-TECH ECOSYSTEM IN THE REGION

Axenya Holdings Inc | August 04, 2022 | Read time : 02:00 min

AXENYA MERGES

AXENYA, a leading Latin-American digital health start-up company, and HealthCo, a premier data-intensive consulting firm and insurance broker, announce that they have reached an agreement to merge the companies into the leading corporate health-tech ecosystem in the Latin-American region.

The combined companies will serve over 35,000 lives and have the capacity to deliver value across the entire healthcare journey.   The companies expect to more than double that number in the coming year.  All founding and operating teams at HealthCo and Axenya will remain in the company and as shareholders of the new company, which will operate under the Axenya brand.

"The New Axenya marries the most advanced population data science with cutting edge, clinically proven, digital therapeutics", said Mariano García-Valiño, Founder of Axenya.   "The combination creates an unbeatable ecosystem, where we can gather data to analyze large populations, identify care gaps and create perfectly targeted individual digital plans for each person, improving clinical metrics and reducing cost across the entire spectrum".

Axenya, that started operations in 2020, offers software and hardware products that expand the doctor's toolbox, allows them to help their patients achieve higher standards of health and make the overall practice of medicine more personalized and precise. The company is the first member of the Digital Therapeutic Alliance in Latin America and the only company in the region with clinical research published in peer-reviewed journals. HealthCo is one of the most advanced data-intensive healthcare brokers in the region and approaching 90 corporate clients.  Their proprietary data analytics result in consistent savings for their client base.

The combination becomes a one stop shop to enable corporate clients to maximize quality and expense in all aspects of their healthcare needs: from population analytics, 24/7 monitoring and course correction, delivering individually selected next generation digital therapeutic tools and ultimately renegotiating fees with payors driven by the savings generated by its healthcare program. As a result, Axenya will deliver unparalleled clinical results, user satisfaction and cost savings.

"We now have a company that can deliver results like nobody else in the market. Using a combination of software, technology, machine learning and behavioral and data science, Axenya can optimize the healthcare journey end-to-end, empowering companies and its employees with unbiased information, trusted guidance and high-value care, and delivering, at the same time, effective cost savings."

Roberto Vianna, co-Founder of HealthCo

In combination with this merger, Axenya received a capital injection, led by IGAH ventures, and with participation of NXTP, Big_Bets, Alexia, Axenya's founder Mariano Garcia-Valiño and several individual investors and employees.

ABOUT AXENYA
Axenya is a health technology company that seeks to connect Latin America with the future of medicine. With its digitally enhanced corporate health ecosystem, it offers and manages the most suitable healthcare plans in a digital, efficient and transparent fashion, protecting the employee's health, end to end, through all the journey. Integrating cutting edge software, hardware, artificial intelligence, intensive data-analysis and behavioral sciences, Axenya improves the efficiency in delivering health services, as well as expands the companies' toolbox and makes medicine more personal and precise, offering what is effectively a new care standard. The company delivers excellent patient satisfaction, superior clinic results and lower costs, improving the quality per dollar spent by companies while allowing access to modern medicine to all employees and dependents.

Spotlight

Artificial Intelligence (AI) in healthcare can turn 30-60 minute manual calculations to having answers on patients in seconds. Learn more about what AI can mean for your organization in this report. Connections between IT Infrastructure and Clinical Excellence, The role of Flash Storage for Clinical Researchers and IT, Economic advantages and opportunities unlocked by AI.

Spotlight

Artificial Intelligence (AI) in healthcare can turn 30-60 minute manual calculations to having answers on patients in seconds. Learn more about what AI can mean for your organization in this report. Connections between IT Infrastructure and Clinical Excellence, The role of Flash Storage for Clinical Researchers and IT, Economic advantages and opportunities unlocked by AI.

Related News

HEALTH TECHNOLOGY

Avail Reaches Significant Network Expansion Milestone with the Signing of its 50th MedTech Contract

Avail Medsystems | August 05, 2022

Avail, the digital hub of the operating room enabling the medical technology and healthcare industries to work smarter to advance patient care, announced the addition of a 50th MedTech organization to its telepresence network. With the signing of this contract, the Avail platform is poised to enable hundreds of thousands of people to collaborate, educate, and share surgical and MedTech expertise between operating rooms and remote locations in real time. "The Avail platform was built to connect the MedTech industry more frequently, efficiently and seamlessly to surgeons and interventionalists, enabling them to work together more closely to advance medicine. With this exciting milestone, the digital evolution of MedTech is well underway. Many of our MedTech partners are integrating Avail into their daily processes to expand the productivity and reach of their commercial teams, thus helping representatives to better engage with customers and support their success." Daniel Hawkins, CEO of Avail For some of the world's largest and most respected MedTech companies specializing in devices for neurosurgery, interventional cardiology, interventional radiology, vascular surgery, and orthopedic surgery, among others — Avail has positively changed business practices in myriad ways. These include enabling faster product training and expanded reach for field teams, dramatically increasing the time they have available to sell products and support live procedures. In addition, MedTech companies and surgeons have realized the mutual benefits of using Avail to collaborate during unplanned cases when field representatives are unable to reach remote locations to join in person. With skyrocketing travel costs and staff shortages, Avail's approach to collaboration has allowed physician education and product launch programs not only to continue, but to operate more efficiently and rapidly. Other uses include enabling the acceleration of product innovation by allowing engineering and R&D teams to better connect with providers. "As far as technology goes, the Avail experience has completely raised the bar for our Professional Education Programs — Avail makes us look good," stated John Vogrin, Senior Manager, Surgical Care Services for Cochlear Americas. "But more importantly, using Avail has allowed Cochlear to reduce travel for members of our sales team and give them back countless hours of their personal lives while improving the training experience and shortening the time it takes to complete. It's a win-win-win-win for our company, employees, customers, and their patients." Avail's footprint of consistent, purpose-built hardware in procedure rooms, along with integrated software created for that hardware, serves as the foundation of the company's surgical telepresence platform. The mobile Avail console includes edge-based computing and a large display monitor and is connected securely to the cloud to stream high-quality audio, video, and surgical imaging to remote participants in a HIPAA-HITECH protected environment. "Future-forward MedTech companies and healthcare systems not only need better, faster means of collaboration, but they want a way to share their own software capabilities to and from the OR," stated James Domine, CTO of Avail. "Avail's consistent hardware footprint provides eyes and ears into the operating room and will also enable the sharing of applicable third-party software capabilities, including AI and machine learning, which can be displayed on the large Avail console monitor to further elevate the collaborative experience. This can help improve processes and speed the adoption of new products that better meet the changing healthcare environment." News of the 50th MedTech contract follows Avail's recent announcements of another company expansion and a partnership with the Stroke Thrombectomy and Aneurysm Registry (STAR), which enables participating neurosurgeons to collaborate and share expertise, regardless of their locations. About Avail Medsystems Avail enables the MedTech industry and healthcare providers to work together more often and more efficiently, harnessing expertise and technology in and out of the OR to accelerate the innovation, adoption, and reach of tools and techniques to improve patient care. Avail does this by placing a consistent, mobile, hardware platform with integrated software into operating rooms, audibly and visually connecting remote participants and serving as the hub for advanced digital capabilities including AI and machine learning, in a secure cloud-based digital telepresence network. Today, 50 MedTech organizations have contracted with Avail to rethink commercial models, reduce inefficiencies, and enhance the reach and timeliness of collaboration. Avail was founded in 2017 by MedTech veterans with a vision to leverage Silicon Valley technology expertise to evolve the industry and enable MedTech and healthcare to deliver the best care possible. Avail.io

Read More

HEALTH TECHNOLOGY

Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants

Conformis, Inc. | August 02, 2022

Conformis, Inc. a leading medical device company that features personalized knee and hip replacement products, announced it has entered into a multi-year agreement with Vizient, Inc., the nation's largest member-driven health care performance improvement company. “We are excited to offer personalized orthopedic implants to Vizient’s large membership of healthcare facilities through this contract. As more orthopedic patients and surgeons seek personalized solutions, increased awareness and ease of access to our product portfolio is more important than ever. The Vizient agreement connects us to a significant number of providers, many of which have limited access and awareness of our products and our new Platinum Services Program,” Mark Augusti, Chief Executive Officer and President of Conformis The agreement gives increased access to the entire Conformis knee and hip portfolio to Vizient’s membership base, which is comprised of academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers, and includes Identity Imprint™, a personalized knee replacement system; Image-to-Implant® Platinum Services Program, a patient-elected deluxe upgrade option to obtain a fully personalized knee replacement implant; and, Cordera™ Match Hip System, a personalized primary hip replacement solution. Conformis implants improve efficiency and reduce overall costs for medical facilities. Researchers at the University of Washington in Seattle found that fully personalized total knee arthroplasty is cost-effective in comparison to a standard, off-the-shelf implant. Ongoing research suggests that fully personalized implants further reduce total costs to the healthcare system because patients recover more quickly and are less likely to require follow-up corrective surgeries. About Conformis, Inc. Founded in 2004, Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant® Platinum Services℠ Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box™ delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

Read More

HEALTH TECHNOLOGY

Biobeat joins Innovators' Network at American Heart Association Center for Health Technology & Innovation

Biobeat | September 07, 2022

Biobeat, a company focused on remote patient monitoring platforms with artificial intelligence analysis capability, has joined the American Heart Association Center for Health Technology & Innovation's (the Center) Innovators' Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions. The Innovators' Network is a consortium that connects entrepreneurs, providers, researchers and payers. Innovators' Network members also have access to the Association's digital guidelines, recommendations, and best-in-class science as they develop digital healthcare technologies. Members collaborate with the Center in different ways, including the building of models for clinical outcome studies, lowering the significant cost of developing those studies independently, helping connect the science to technology, and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers. "The Center aims to advance the rapid, efficient, and effective development of healthcare technology," said Robert A. Harrington, M.D., FAHA, past president of the American Heart Association (2019-2020), volunteer chair of the American Heart Association's Health Tech Advisory Group for the Center and Arthur L. Bloomfield professor and chair department of medicine, Stanford University. "Joining the Innovators' Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena." "Biobeat is excited to join the Innovators' Network. It will provide unique access to the Association's research and others innovating in this space, helping us to achieve our goals of improving cardiovascular health and helping health care providers." Arik Eisenkraft, MD, VP Clinical and Regulation at Biobeat About Biobeat Biobeat joins the Innovators' Network bringing with them the Biobeat solution, the first cuffless blood pressure measurement tool to receive FDA clearance. Biobeat leverages health-related artificial intelligence and med-tech capabilities to collect and analyze patient data with a suite of optical-based sensor monitors and machine learning data platforms focused on actionable insights. Wireless sensors worn on the wrist or chest allow remote patient monitoring for blood pressure and multiple physiological parameters. Patient health data is viewed by participating medical staff via Biobeat's secure HIPAA and GDPR compliant cloud-based patient management platform. The platform includes an automated real-time early warning score system that incorporates advanced artificial intelligence algorithms to provide alerts on patient health status. These capabilities are centered on supporting medical teams in providing tailored patient care such as adjustment of therapeutics and early prevention of specific disease exacerbations. The company anticipates that compliance with easy-to-wear cuffless health sensor solutions will help healthcare professionals engage in timely, proactive care for hypertension patients.

Read More